Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 5, 2012, Pages 484-496

  Kaur, Indu Pal ^a   Rana, Cheena ^a   Singh, Manjit ^b   Bhushan, Shashi ^c   Singh, Harinder ^a   Kakkar, Shilpa ^a  

^a PANJAB UNIVERSITY   (India)

^b CIVIL HOSPITAL   (India)

^c CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ETHER; FLUCONAZOLE; NIOSOME; SORBITAN;

AMES TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CONTROLLED STUDY; CORNEA PERMEABILITY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG SAFETY; DRUG SOLUTION; EX VIVO STUDY; EXPERIMENTAL RABBIT; EYE IRRITATION; GENOTOXICITY; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; PARTICLE SIZE; PERITONEUM MACROPHAGE; PSEUDOMONAS AERUGINOSA; SKIN IRRITATION; STAPHYLOCOCCUS AUREUS; TEAR FILM;

ANIMALS; ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE; CELL SURVIVAL; CORNEA; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; ELASTICITY; FLUCONAZOLE; MACROPHAGES, PERITONEAL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PERMEABILITY; RABBITS; SKIN; SKIN IRRITANCY TESTS; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; SWINE;

EID: 84866972676     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0176     Document Type: Article

References (53)

1. Hoflin-Lima, A.L., and Roizenblatt R. Therapeutic contact lens-related bilateral fungal keratitis. CLAO J. 28:149-150, 2002.
2. Chowdhary, A., and Singh K. Spectrum of fungal keratitis in North India. Cornea 24:8-15, 2005.
3. Williamson, J., Gordon, A.M., Wood, R., Dyer, A.M., and Yahya, O.A. Fungal flora of the conjunctival sac in health and disease. Br. J. Ophthalmol. 52:127-137, 1968.
4. Rosa, R.H., Miller, D., and Alfonso, E.C. The changing spectrum of fungal keratitis in South Florida. Ophthalmology 101:1005-1012, 1994.
5. Sharma, S., Srinivasan, M., and George, C. The current status of Fusarium species in mycotic keratitis in South India. J. Med. Microbiol. 11:140-147, 1993.
6. Manzouri, B., Vafidis, G.C., and Wyse, R.K. Pharmacotherapy of fungal eye infections. Expert Opin. Pharmacother. 2:1849-1857, 2001.
7. Kaur, I.P., Smitha, R., Aggarwal, D., and Kapil, M. Acetazolamide: future perspective in topical glaucoma therapeutics. Int. J. Pharm. 248:1-14, 2002.
8. Le Bourlais, C., Acar, L., Zia, H., Sado, P.A., Needham, T., and Leverge, R. Opthalmic drug delivery systems-recent advances. Prog. Retin. Eye Res. 17:33-58, 1998.
9. Shell, J.W., and Baker, R. Diffusional system for controlled release to the eye. Ann. Ophthalmol. 6:1037-1043, 1974.
10. Burstein, N.L., and Anderson, J.A. Review: corneal penetration and ocular availability of drugs. J. Ocul. Pharmacol. 1:309-326, 1985.
11. Shell, J.W. Ophthalmic drug delivery systems. Surv. Ophthalmol. 29:117, 1984.
12. Kakkar, S., and Kaur, I.P. Spanlastics-A novel nanovesicular carrier system for ocular delivery. Int. J. Pharm. 413:202-210, 2011.
13. Yee, R.W., Cheng, C.J., Meenakshi, S., Ludden, T.M., Wallace, J.E., and Rinaldi, M.G. Ocular penetration and pharmacokinetics of topical fluconazole. Cornea 16:64-71, 1997.
14. Robert, M.E.M., and Kalia, Y.N. New development in topical antifungal therapy. Am J. Drug Deliv. 4:231-247, 2006.
15. Cevc, G., and Blume, G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104:226-232, 1992.
16. Van den Bergh, B.A.I., Bouwstra, J.A., Junginger, H.E., and Wertz, P.W. Elasticity of vesicles affects hairless mouse skin structure and permeability. J. Control Release 62:367-379, 1999.
17. Touitou, E., Alkabes, M., and Dayan, N. Ethosomes: novel lipid vesicular system for enhanced delivery. Pharm. Res. S14:305-306, 1997.
18. Cevc, G., Blume, G., Schatzlein, A., Gebauer, D., and Paul, A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev. 18.349-378, 1996.
19. Touitou, E., Dayan, N., Bergelson, L., Godin, B., and Eliaz, M. Ethosomes-novel vesicular carriers: characterization and delivery properties. J. Control Release 65:403-418, 2000.
20. Vaibhav, D., Dinesh, M., Tathagata, D., Manoj, N., Saraf, D.K., and Jain, N.K. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Control Release 123:148-154, 2007.
21. Shen, Y., and Tu, J. Preparation and Ocular Pharmacokinetics of Ganciclovir Liposomes. AAPS J. 9:E371-E377, 2007.
22. Benson, H.A.E. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv. 3:727-737, 2006.
23. Ballie, A.J. The preparation and properties of niosomes-nonionic surfactant vesicles. J. Pharm. Pharmacol. 37:863-868, 1985.
24. United States Pharmacopeia National Formulary (USP NF-29) Residual Solvents. In: U.S. Pharmacopeia. 2009; p. 171-182. United State Pharmacopeial Convention, Maryland, USA.
25. Chatterjee, C.C. Human Physiology. Vol. I, 11th ed. Calcutta: Medical Allied Agency; 1985; 174.
26. Ballie, A.J. The preparation and properties of niosomes-nonionic surfactant vesicles. J. Pharm. Pharmacol. 37:863-868, 1985.
27. Martin, A. Physical Pharmacy. Delhi: Waverly Pvt. Ltd.; 2010.
28. van den Bergh, B.A., Wertz, P.W., Junginger, H.E., and Bouwstra, J.A. Elasticity of vesicles assessed by electron spin resonance, electron microscopy, and extrusion measurement. Int. J. Pharm. 217:13-24, 2001.
29. Aggarwal, D., Garg, A., and Kaur, I.P. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. J. Pharm. Pharmacol. 56:1-9, 2004.
30. Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F.J., Khar, R.K., and Ali, M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 66:227-224, 2007.
31. Maron, D.M., and Ames, B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:173-215, 1983.
32. Malik, F., Khajuria, A., Suri, K.A., Satti, N.K., Singh, S., Kaul, M.K., Kumar, A., Bhatia, A., and Qazi, G.N. A standardized root extract of Withania somnifera and its major constituent withanolide-A solicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci. 80:1525-1538, 2007.
33. Acute dermal irritation/corrosion. In: OECD, ed. Test Guideline 404, 2002. OECD Publishing, Paris, France.
34. Acute eye irritation/corrosion. In: OECD, ed. Test Guideline 405, 2002. OECD Publishing, Paris, France.
35. British Pharmacopoeia. London, UK: The Stationary Office; 1999.
36. Kaur, I.P., Lal, S., Rana, C., Kakkar, S., and Singh, H. Ocular preservatives: associated risks and newer options. Cutan. Ocul. Toxicol. 28:93-103, 2009.
37. Fialho, S.L., and da Silva-Cunha, A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin. Exp. Ophthalmol. 32:626-632, 2004.
38. Aggarwal, D., and Kaur, I.P. Improved pharmacodynamics of timolol maleate from mucoadhesive niosomal ophthalmic drug delivery system. Int. J. Pharm. 290:155-159, 2005.
39. Hillgren, A., Evertsson, H., and Aldén, M. Interaction between lactate dehydrogenase and Tween 80 in aqueous solution. Pharm. Res. 19:504-510, 2002.
40. Liu, Z., Li, J., Nie, S., Liu, H., Ding, P., and Pan, W. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int. J. Pharm. 315:12-17, 2006.
41. Cevc, G., Schatzlein, A., Gebauer, D., and Blume, G. Ultrahigh efficiency of drug and peptide transfer through the intact skin by means of novel drug-carriers, Transfersomes. In: Brain, K.R., James, V.J., and Walters, K.A., eds. Prediction of Percutaneous Penetration. Vol. 3B. Cardiff, UK: STS Publishing; 1993; p. 226-236.
42. Cevc, G. Lipid vesicles and other colloids as drug carrier on the skin. Adv. Drug Dev. 56:675-711, 2004.
43. Cevc, G., Gebauer, D., Stieber, J., Schatzlein, A., and Blume, G. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368:201-215, 1998.
44. Planas, M.E., Gonzalez, P., Rodriguez, L., Sanchez, S., and Cevc, G. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth. Analg. 75:615-621, 1992.
45. van den Bergh, B.A., Vroom, J., Gerritsen, H., Junginger, H.E., and Bouwstra, J.A. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim. Biophys. Acta 1461:155-173, 1999.
46. Honeywell-Nguyen, P.L., Van Den Bussche, M.H., Junginger, H.E., and Bouwstra, J.A. The effect of surfactant-based elastic and rigid vesicles on the penetration of lidocaine across human skin. STP Pharma. Sci. 12:257-262, 2002.
47. Honeywell-Nguyen, P.L., Frederik, P.M., Bomans, P.H., Junginger, H.E., and Bouwstra, J.A. Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterisation and in vitro transport studies. Pharm. Res. 19:992-998, 2002.
48. Yoshioka, T., Sternberg, B., and Florence, A.T. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60 and 80) and a sorbitan triester (span 85). Int. J. Pharm. 105:1-6, 1994.
49. De Gier, J., Mandersloot, J.G., and Van Deenen, L.L.M. Lipid composition and permeability of liposomes. Biochim. Biophys. Acta 150:666-675, 1968.
50. Hecht, G. Ophthalmic preparations. In: Gennaro, A.R. ed. Remington: The Science and Practice of Pharmacy. Lipincott Williams and Wilkins; 2001; p. 821-833.
51. Rosen, M. Surfactants and Interfacial Phenomenon. 3rd ed. Hoboken: John Wiley and Sons; 2004.
52. Mathis, G.A. Clinical ophthalmic pharmacology and therapeutics: ocular drug delivery. In: Gelatt, K.N., ed. Veterinary Ophthalmology. Philadelphia: Lippincott William & Wilkins; 1999; p. 291-297.
53. Kaur, I.P., and Smitha, R. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 28:353-369, 2002.